Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fernandez

Showing results (621-630 of 645) with videos related to

Pageof 65
Sort By:
Parkinsonism & Related Disorders|October 25, 2021
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsAngelo Antonini, Per Odin, Peter Schmidt, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 7, 2010
Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopauseH Marret, A Fauconnier, N Chabbert-Buffet, et al.
Neuro-Degenerative Diseases|July 12, 2007
Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutationJanel Johnson, Coro Paisán-Ruíz, Grisel Lopez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 30, 2014
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label resultsHubert H Fernandez, David G Standaert, Robert A Hauser, et al.
Environmental Health Perspectives|January 29, 2011
Rotenone, paraquat, and Parkinson's diseaseCaroline M Tanner, Freya Kamel, G Webster Ross, et al.
The Lancet. Neurology|October 21, 2006
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of dataHon-Chung Fung, Sonja Scholz, Mar Matarin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trialsAnthony E Lang, Ramon L Rodriguez, James T Boyd, et al.
Acta Neuropathologica Communications|December 2, 2020
Clusterin ameliorates tau pathology in vivo by inhibiting fibril formationAleksandra M Wojtas, Yari Carlomagno, Jonathon P Sens, et al.
Parkinsonism & Related Disorders|March 9, 2020
Delivering patient-centered care in Parkinson's disease: Challenges and consensus from an international panelRoongroj Bhidayasiri, Pattamon Panyakaew, Claudia Trenkwalder, et al.
Brain Pathology (Zurich, Switzerland)|March 12, 2021
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficitsRosa Rademakers, Alexandra M Nicholson, Yingxue Ren, et al.
Pageof 65

Showing results (621-630 of 645) with videos related to

Sort By:
Pageof 65
Parkinsonism & Related Disorders|October 25, 2021
Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsAngelo Antonini, Per Odin, Peter Schmidt, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 7, 2010
Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopauseH Marret, A Fauconnier, N Chabbert-Buffet, et al.
Neuro-Degenerative Diseases|July 12, 2007
Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutationJanel Johnson, Coro Paisán-Ruíz, Grisel Lopez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 30, 2014
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label resultsHubert H Fernandez, David G Standaert, Robert A Hauser, et al.
Environmental Health Perspectives|January 29, 2011
Rotenone, paraquat, and Parkinson's diseaseCaroline M Tanner, Freya Kamel, G Webster Ross, et al.
The Lancet. Neurology|October 21, 2006
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of dataHon-Chung Fung, Sonja Scholz, Mar Matarin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 24, 2015
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trialsAnthony E Lang, Ramon L Rodriguez, James T Boyd, et al.
Acta Neuropathologica Communications|December 2, 2020
Clusterin ameliorates tau pathology in vivo by inhibiting fibril formationAleksandra M Wojtas, Yari Carlomagno, Jonathon P Sens, et al.
Parkinsonism & Related Disorders|March 9, 2020
Delivering patient-centered care in Parkinson's disease: Challenges and consensus from an international panelRoongroj Bhidayasiri, Pattamon Panyakaew, Claudia Trenkwalder, et al.
Brain Pathology (Zurich, Switzerland)|March 12, 2021
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficitsRosa Rademakers, Alexandra M Nicholson, Yingxue Ren, et al.
Pageof 65